Bengaluru, Aug 6 (PTI): Karnataka Health Minister Dinesh Gundu Rao has defended the state government’s decision to discontinue Jan Aushadhi Kendras operating within government hospital premises, saying the move is intended to ensure the free and assured supply of essential medicines to patients and to reduce their out-of-pocket expenditure.

Rao’s clarification came in response to concerns raised by Union Health Minister Jagat Prakash Nadda in a recent letter to Chief Minister Siddaramaiah regarding the closure of JAKs within government hospitals in Karnataka.

In a letter addressed to Nadda on August 5, Rao stated that the Karnataka government is committed to the free supply of all essential medicines, as listed in the Essential Medicines List (EML), across government healthcare institutions.

To streamline public healthcare delivery and eliminate the risk of patients being denied medicines at government facilities, the State Government has directed that prescriptions by government doctors be limited to medicines available within the hospital supply, Rao said.

He further explained that medicines are regularly provided to government hospitals through the Karnataka State Medical Supplies Corporation Limited (KSMSCL). Hospitals have also been allocated sufficient funds and have standing instructions to purchase medicines locally in case of any shortage.

"This effort aims to ensure universal access to essential medicines for patients visiting government hospitals—entirely free of cost," Rao said.

Justifying the move to discontinue JAKs within government hospital premises, the minister said the decision was taken to prevent doctors from directing patients to purchase medicines from these outlets, thereby ensuring they are not denied free medicines available at the hospitals.

"However, this decision does not restrict the operation of Jan Aushadhi Kendras outside government premises. Citizens remain free to access them as per their choice," Rao clarified.

He noted that Karnataka ranks among the top states in terms of the number of operational JAKs, with over 1,417 currently functioning.

Of these, only 184 are located within the premises of government hospitals under the Department of Health and Family Welfare, while the rest operate independently outside government campuses.

"This move is primarily aimed at benefiting poor and marginalised patients who rely heavily on government hospitals for healthcare," Rao said.

Highlighting the affordability of medicines sold under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), Rao noted that the scheme offers medicines at prices 50-80 per cent lower than branded alternatives. He added that PMBJP is implemented by the Pharma and Medical Bureau of India (PMBI), a society registered under the Societies Registration Act.

"It is requested that PMBI be directed to supply medicines to the Karnataka Health Department at the same rates offered to JAKs. This will go a long way in supporting the state’s free drug supply initiative," Rao urged in the letter.

Reiterating the state’s commitment to affordable and quality healthcare, Rao said Karnataka is continually working to improve its public health supply chain and ensure rational medicine usage.

"We deeply value your concern for public health and reaffirm our shared commitment to the welfare of the people," he concluded.

Get all the latest, breaking news from Karnataka in a single click. CLICK HERE to get all the latest news from Karnataka.

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



Bengaluru (PTI): Karnataka Commerce and Industries Minister M B Patil on Monday asserted that Aequs continues to expand in the state and that its proposed investment in neighbouring Tamil Nadu was a business decision aimed at diversification, not a shift away from Karnataka.

Reacting to criticism on social media over reports that the Karnataka-based firm had signed a major investment deal in Tamil Nadu's Krishnagiri district for setting up a specialised aerospace and defense manufacturing cluster, he said the state government was fully aware of the company's plans and remained confident about its long-term commitment to Karnataka.

"While we welcome every major investment in India, would like to clarify a few points," Patil said in a post on 'X'.

Aequs was significantly expanding its footprint within Karnataka, including a Rs 3,000 crore investment in Kolar for electronics manufacturing.

"Its recently approved Rs 1,500 crore ECMS project will also be grounded in the state. Karnataka remains central to its long-term strategy," he said.

Patil added that the government had prior knowledge of the TN proposal.

The government was already informed and aware that the TN investment is a business decision aimed at geographic diversification and de-risking operations, not a shift away from Karnataka.

"Healthy competition between states strengthens India's manufacturing ecosystem," he said.

Emphasising the state's focus on high-technology sectors, Patil said, "We remain committed to deepening Karnataka's leadership in aerospace and advanced manufacturing, and our engagement with industry partners is strong and ongoing."

The Aequs Group has pledged Rs 4,000 crore to bolster Tamil Nadu's aerospace manufacturing capabilities at the SIPCOT-Shoolagiri Industrial Park in Krishnagiri district.

The group proposes to establish a specialised aerospace and defense manufacturing cluster for the production of aircraft engines, gearbox components, and precision engineering parts. This initiative is expected to provide employment to 7,000 individuals.